Biopharmaceuticals in China

Biotechnology Journal

Volumn 1, Issue 11, 2006, Pages 1215-1224

  Hu, Xianwen ^a   Ma, Qingjun ^a   Zhang, Shuyong ^b  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^b Chinese Society of Biotechnology   (China)

Author keywords

Biopharmaceuticals; China; Top sale

Indexed keywords

ANNUAL GROWTH RATE; BIOPHARMACEUTICAL INDUSTRY; BIOPHARMACEUTICALS; BIOTECH DRUGS; CHINA; CYTOKINES; GLOBAL MARKET; HIGH-TECH INDUSTRIES; INDUSTRIAL BIOTECHNOLOGY; STATE FOOD AND DRUG ADMINISTRATIONS; THERAPEUTIC ANTIBODIES; TOP-SALE;

DRUG PRODUCTS; GENETIC ENGINEERING; INDUSTRY; INTERNATIONAL TRADE;

ANTIBODIES;

BIOLOGICAL PRODUCT; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

ACTIVE IMMUNIZATION; ANIMAL; BIOTECHNOLOGY; CHEMISTRY; CHINA; CHINESE MEDICINE; GENE THERAPY; GENETIC ENGINEERING; HUMAN; METHODOLOGY; PHARMACEUTICS; PROTEIN ENGINEERING; REVIEW;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOLOGICAL PRODUCTS; BIOPHARMACEUTICS; BIOTECHNOLOGY; CHINA; GENE THERAPY; GENETIC ENGINEERING; HUMANS; IMMUNOTHERAPY, ACTIVE; MEDICINE, CHINESE TRADITIONAL; PROTEIN ENGINEERING; RECOMBINANT PROTEINS;

EID: 34547554168     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.200600083     Document Type: Review

References (23)

1. Johnson, I. S., The trials and tribulations of producing the first genetically engineered drug. Nat. Rev. Drug Discov. 2003, 2, 747-751.
2. Walsh, G., Biopharmaceutic benchmarks-2003. Nat. Biotechnol. 2003, 21, 870-878.
3. Bibby, K., Davis, J., Jones, C., Biopharmaceuticals-Moving to Centre Stage. 2003 BioPeople North American Biotechnology Industry and Suppliers' Guide. 3-11, 2003. [30 October 2005] (http://www.imshealth.com/vgn/images/portal/cit_40000873/43028586Bio_Moving_to_Centre_Stage.pdf).
4. Hu, X. W., Chen, H. P., Tang, Z. M., Ma, Q. J., Comparison of approval biomedicines among USA, EU and China. China Biotechnol. 2005, 25, 82-94.
5. Hu, X. W., Ma, Q. J., The present and the trends of biopharmaceutical industry. In: Chinese Society of Biotechnology (ed.), Annual Report on Bioindustry in China: 2005. Chemical Industry Press, Beijing 2006, pp. 43-92.
6. Hu, X. W., Chen, H. P., Tang, Z. M., Ma, Q. J., The present and the future of biopharmaceuticals (1): history and today's market. China Biotechnol. 2004, 24, 95-101.
7. Hu, X. W., Chen, H. P., Tang, Z. M., Ma, Q. J., The present and the future of biopharmaceuticals (2): trends and prospects. China Biotechnol. 2005, 25, 86-93.
8. 2005 Beijing Pharma and Biotech Center, Annual report for development of Beijing Pharma & Biotech industry: 2005. China Science Press
9. Rouhi, A. M., Generic tide is rising. Chem. Eng. News 2002, 80, 37-51.
10. Rouhi, A. M., Generics next wave: biopharmaceuticals. Chem. Eng. News 2002, 80, 61-65.
11. Peng, Z. H., Current status of Gendicine in China: recombinant human Ad-p53 agent for treatment of cancers. Hum. Gene Ther. 2005, 16, 1016-1027.
12. Cohen, E. E., Rudin, C. M., ONYX-015. Onyx Pharmaceuticals. Curr. Opin. Investig. Drugs 2001, 2, 1770-1775.
13. Chen, S. L., Yu, L., Jiang, C. Y., Zhao, Y. et al., Pivotal study of iodine-131-labeled chimeric tumor necrosis treatment radioimmunotherapy in patients with advanced lung cancer. J. Clin. Oncol. 2005, 23, 1538-1547.
14. Crombet, T., Osorio, M., Cruz, T., Roca, C. et al., Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients. J. Clin. Oncol. 2004, 22, 1646-1654.
15. Bao, G. Q., Li, Y., Ma, Q. J, He, X. L. et al., Isolating human antibody against human hepatocellular carcinoma by guided-selection. Cancer Biol. Ther. 2005, 4, 1374-1380.
16. Zhen, P., Yu, S. Y., Chen, Q., Ma, Q. J. et al., Field trial and evaluation of oral-administered lyophilized rBS-WC cholera vaccine (Capsule). Chin. J. Vaccines Immunization 1999, 5, 210-214.
17. Clemens, J. D., Sack, D. A., Harris, J. R., Chakraborty, J. et al., Field trial of oral cholera vaccines in Bangladesh. Lancet 1986, 2, 124-127.
18. Sanchez, J. L., Vasquez, B., Begue, R. E., Meza, R. et al., Protective efficacy of oral whole-cell/ recombinant-B-subunit cholera vaccine in Peruvian military recruits. Lancet 1994, 344, 1273-1276.
19. Lucas, M. E. S., Deen, J. L., von Seidlein, L., Wang, X. Y. et al., Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N. Engl. J. Med. 2005, 352, 757-767.
20. Wurm, F. M., Production of recombinant protein therapeutics in cultivated mammalian cells. Nat. Biotechnol. 2004, 22, 1393-1398.
21. Thiel, K. A., Biomanufacturing, from bust to boom to bubble? Nat. Biotechnol. 2004, 22, 1365-1372.
22. Hu, X. W., Xiao, C., Huang, Z., Guo, Z. et al., Pilot production of u-PA with porous microcarrier cell culture. Cytotechnology 2000, 33, 13-19.
23. Hu, X. W., Xiao, C. Z., Li, Z. H., Guo, Z. X. et al., Production of u-PA by rCHO cell culture on porous microcarriers in serum-free growth medium. Chin. J. Biotechnol. 2000, 16, 387-391